Kerry Sieger
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 2
- Metabolism, Diabetes, and Cancer 1
- Oncology 5
- Cytokine Signaling Pathways and Interactions 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Abner M. Mhashilkar (7 shared papers)Sunil Chada (7 shared papers)Rajagopal Ramesh (6 shared papers)Elizabeth A. Grimm (4 shared papers)Alexis Stewart (4 shared papers)Yuji Saito (3 shared papers)Cynthia D. Branch (2 shared papers)Tomoyuki Saeki (2 shared papers)
- Journals
- Molecular Therapy (2 papers)Molecular Medicine (2 papers)The Journal of Immunology (1 paper)Oncogene (1 paper)Molecular Endocrinology (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Kerry Sieger
9 papers receiving 766 citations
Peers
Comparison fields: 5 of 65
- Oncology 437
- Biotechnology 128
- Genetics 358
- Immunology 246
- Molecular Biology 362
Countries citing papers authored by Kerry Sieger
This map shows the geographic impact of Kerry Sieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Sieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Sieger more than expected).
Fields of papers citing papers by Kerry Sieger
This network shows the impact of papers produced by Kerry Sieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Sieger. The network helps show where Kerry Sieger may publish in the future.
Co-authors
The 25 scholars most cited alongside Kerry Sieger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. | 2003 | 160 |
| 2 | 2001 | 143 | |
| 3 | 2002 | 127 | |
| 4 | 2003 | 78 | |
| 5 | 2004 | 70 | |
| 6 | 2002 | 68 | |
| 7 | 2000 | 65 | |
| 8 | 1995 | 43 | |
| 9 | 2004 | 21 |
About Kerry Sieger
Kerry Sieger is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Pharmacology, having authored 9 papers that have together received 775 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (3 papers), Cancer-related Molecular Pathways (2 papers), Virus-based gene therapy research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Ubiquitin and proteasome pathways (2 papers), interferon and immune responses (1 paper), Mast cells and histamine (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Oncology (437 citations), Biotechnology (128 citations), Genetics (358 citations), Immunology (246 citations) and Molecular Biology (362 citations). Kerry Sieger has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Abner M. Mhashilkar, Sunil Chada, Rajagopal Ramesh, Elizabeth A. Grimm, Alexis Stewart, Yuji Saito, Cynthia D. Branch, Tomoyuki Saeki, Jack A. Roth and Raymond E. Meyn. Their work appears in journals such as Molecular Therapy, Molecular Medicine, The Journal of Immunology, Oncogene and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.